

<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xmlns:xlink="https://www.w3.org/1999/xlink">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Avicenna J Med Biotech</journal-id>
      <journal-id journal-id-type="publisher-id">arij002</journal-id>
      <journal-title-group>
        <journal-title>Avicenna Journal of Medical Biotechnology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2008-2835</issn>
      <issn pub-type="epub">2008-4625</issn>
      <publisher>
        <publisher-name>Avicenna Research Institute</publisher-name>
      </publisher>
    </journal-meta>

    <article-meta>
      <article-id pub-id-type="publisher-id">ajmb291</article-id>
      <article-id pub-id-type="doi"></article-id>
      <article-id pub-id-type="pmid"></article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
             <subject></subject> 
        </subj-group>
        <subj-group>
            <subject></subject>
        </subj-group> 
      </article-categories>
      <title-group>
        <article-title>Retraction: The Frequency and Importance of Common α-globin Gene Deletions Among β-Thalassemia Carriers in an Iranian Population</article-title>
      </title-group>
        <contrib-group><contrib contrib-type="author"><name><surname>Moosavi</surname><given-names>Azam</given-names></name></contrib><aff>Department of Biochemistry, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>M. Ardekani</surname><given-names>Ali</given-names></name></contrib><aff>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR      , Tehran, Iran</aff></contrib-group>
      <pub-date pub-type="ppub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <pub-date pub-type="epub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <volume>9</volume>
      <issue>4</issue>
      <fpage>196</fpage>
      <lpage>200</lpage>
      <history>
        <date date-type="received">
          <day>27</day>
          <month>8</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>28</day>
          <month>12</month>
          <year>2016</year>
        </date>
      </history>
      <abstract>
      <p>
      &lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Background:&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; &amp;beta;&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;-thalassemia&amp;nbsp;is the most common monogenic disorder in Iran, and one of the challenges in the screening of the carriers is the coinheritance of &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&amp;alpha;&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;-thalassemia mutations. In the view of high prevalence of &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&amp;alpha;&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;-thalassemia mutations in many parts of the country, the aim of this study was to determine the carrier frequency&amp;nbsp;of common alpha deletions, as a secondary modifier in clinical manifestations of beta thalassemia, in known beta-thalassemia carriers and some hematology parameter changes. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Methods:&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; The study included families referred from different primary health care centers with microcytic hypochromic anemia [MCV&amp;lt;80fl; MCH&amp;lt;27 &lt;em&gt;pg&lt;/em&gt;]&amp;nbsp;and&amp;nbsp;A2&amp;gt;3.4%]. Genomic DNA was extracted from peripheral blood leukocytes by salting out method. For common &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&amp;beta;&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;-globin gene mutation analysis, amplification refractory mutation system- polymerase chain reaction (ARMS-PCR) and for rare &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&amp;beta;&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;-thal alleles, DNA sequencing were used. Also, for investigation of common &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&amp;alpha;&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;-globin gene cluster deletions (-&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&amp;alpha;&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;3.7, -&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&amp;alpha;&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;4.2, --MED and -&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&amp;alpha;&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;20.5), multiplex Gap-PCR was performed.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Results:&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; Among 227 &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&amp;beta;&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;-thalassemia minor individuals studied, &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&amp;alpha;&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;-globin gene deletions were found in 43 cases:&amp;nbsp;37 heterozygote&amp;nbsp;-&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&amp;alpha;&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;3.7 (16.3%), 5 homo -&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&amp;alpha;&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;3.7 (2.2%) and 1 --MED (0.44%). Also, &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;the co-inheritance of &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&amp;alpha;-globin gene deletion and triplication was not found in the studied individuals.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p&gt;&amp;nbsp;&lt;/p&gt;

&lt;p&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Conclusion:&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; Although it is highly recommended that physicians and genetic counselors involved in the screening program of beta-thal major in the country consider this phenomenon because of high prevalence of this coinheritance, hematologic indices changes are very slight.&lt;/span&gt;&lt;/p&gt;

      </p>
      </abstract>
    </article-meta>
  </front>
    
</article>
